Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s ...

The Parkinson's disease field is considering whether to ... Okun reported relationships with the NIH, Michael J. Fox Foundation, Parkinson's Foundation, Parkinson Alliance, Smallwood Foundation ...

An expert has highlighted a lesser-known symptom related to the nose that could potentially indicate Parkinson's disease.

New research suggests that dancing might lighten the depression suffered by many people with Parkinson’s disease, an approach ...

Initiation of dosing in our Phase 1b clinical trial represents an important step in the clinical development of GT-02287 and in Gain’s mission to deliver a disease-modifying therapy to people with ...

Gain’s lead program in Parkinson’s disease has been awarded funding support early in its development from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Fo ...

Interim Analysis Expected End of 2Q 2025 BETHESDA, MD / ACCESS Newswire / March 14, 2025 / Gain Therapeutics, Inc. (Nasdaq:GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company lead ...

The 22nd Annual CurePSP Awareness and Memorial Walk will take place on March 29th at Mackle Park on Marco Island. The event ...

Hiroshi Sueyoshi’s presence has helped shape the Wilmington art community, where he served as a friend and mentor to ...

A St. Louis-based company known for its work in Alzheimer's and neurological testing can expand its footprint, thanks to a $10 million investment from several life sciences companies.